ClinConnect ClinConnect Logo
Search / Trial NCT06536088

The Relationship Between Gait and Severity of Femoroacetabular Impingement

Launched by GAZI UNIVERSITY · Jul 31, 2024

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is investigating how femoroacetabular impingement (FAI), a condition affecting the hip joint, impacts walking. The study will analyze various walking patterns, such as speed and step length, in patients who have FAI and are scheduled for hip surgery. Researchers will also look at imaging results from X-rays to see how they relate to these walking patterns, comparing FAI patients with healthy individuals. The goal is to understand how FAI affects movement, which can help doctors create better treatment plans.

To participate in this trial, individuals aged between 18 and 75 who have been diagnosed with femoroacetabular impingement and are set to undergo hip arthroscopy may be eligible. However, those with severe hip arthritis, certain hip joint conditions, or prior hip surgeries may not qualify. Participants can expect assessments of their walking patterns and related imaging studies, all aimed at improving understanding and treatment of FAI.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with femoroacetabular impingement scheduled for hip arthroscopy
  • Exclusion Criteria:
  • Severe hip osteoarthritis
  • Hip dysplasia
  • Previous ipsilateral and/or contralateral hip surgery,
  • Any orthopedic or neurologic pathology that may affect gait patterns

About Gazi University

Gazi University, a leading research institution based in Ankara, Turkey, is committed to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university integrates cutting-edge research with clinical practice to explore new therapeutic approaches and enhance existing treatments. Gazi University adheres to the highest ethical standards and regulatory guidelines, ensuring the integrity and safety of its clinical trials. By fostering partnerships with healthcare professionals and academic institutions, Gazi University aims to contribute significantly to the global scientific community and address pressing health challenges.

Locations

Ankara, , Turkey

Patients applied

0 patients applied

Trial Officials

Ulunay Kanatlı, Professor

Study Director

Gazi University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported